ICP-332

· Beijing InnoCare Pharma Tech Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ICP-332, covering 2023-05-22 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria [Phase 2, Phase 3]